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Systemic inflammation for colorectal cancer may be associated with increased risk of 
recurrence. This study investigated whether a clinically suspected infection in which blood 
cultures were sent within 30 days after surgery for colorectal cancer was associated with long-
term oncological outcomes. 
Method 
The study was a register-based national cohort study including all Danish residents 
undergoing curatively intended surgery for colorectal cancer between January 2003 and 
December 2013. Patients with recurrence or death within 180 days after surgery were not 
included. Associations between blood cultures taken within 30 days after primary surgery and 
overall survival, disease-free survival and recurrence-free survival was estimated by Cox 
regression models adjusted for relevant clinical confounders (including demographic data, 
cancer stage, comorbidity, blood transfusion, postoperative complications and adjuvant 
chemotherapy).  
Results 
The study included 21,349 patients of whom 3,390 (16%) had blood cultures taken within 30 
days after surgery. Median follow-up was 5.6 years. Patients who had blood cultures taken 
had increased risk of all-cause mortality (HR 1.27; 95% CI 1.20-1.35; p<0.0001), poorer 






disease-free survival (1.22; 1.16-1.29; p<0.0001), and higher risk of recurrence (1.15; 1.07-
1.23; p<0.0001) than patients that did not have blood cultures taken. 
Conclusions  
A clinically suspected infection requiring blood cultures within 30 days of surgery for 











Tumour development and recurrence depend on multiple interactions between tumour and 
host.1 To metastasize, cancer cells undergo epithelial to mesenchymal transition, immune 
evasion, and tissue invasion2. These events are central elements of the surgical stress response 
and believed to be important for the initiation of the  postoperative metastatic process, which 
may be accelerated by inflammation.3–5  
Blood cultures obtained in the postoperative period is a common event, performed when there 
is a clinical suspicion of bloodstream infection following symptoms such as fever, tachycardia 
or hypotension. The objective of this study was to investigate whether clinical suspicion of a 
bloodstream infection, defined by blood cultures taken within 30 days after surgery for 
colorectal cancer (CRC), was associated with a higher risk of all-cause mortality, disease-free 
















MATERIALS AND METHODS 
Study cohort 
Patients who had surgery for CRC with a curative intent between January 2003 and December 
2013 in Denmark were included through the Danish Colorectal Cancer Group (DCCG) 
national clinical register.6 Patients who died, had a recurrence or a new cancer diagnosis 
within 180 days after surgery were not included. From DCCG demographic data and 
information regarding type of cancer, surgery, and operative and postoperative details were 
obtained. Complications were grouped in infectious complications including anastomotic 
leakage, abscess formation, pneumonia, and sepsis and non-infectious complications 
including bleeding, ileus, embolism, myocardial infarction, cerebral apoplexy, deep venous 
thrombosis, heart failure, respiratory insufficiency, kidney insufficiency, and wound 
dehiscence.     
Blood cultures showing growth of gram positive and negative bacteria or fungi were regarded 
as true bloodstream infection except for the skin commensals: coagulase-negative 
staphylococci, Propionibacterium, Bacillus, Micrococcus or Corynebacterium species, which 
were regarded as contamination. Any positive blood culture within 30 days after surgery was 
combined as one culture positive episode for the statistical analysis. 
Data collection 






Danish residents have a unique personal identifier that enables linkage of data between 
registries7,8 The National Patient Register (NPR) records all visits to hospitals, and from here, 
information on hospital admissions, discharges, outpatient visits, procedure codes, diagnostic 
codes and Charlson Comorbidity Index (CCI) grouped in 3 levels: 1, 2 and 3+, was obtained. 
9   
The Danish microbiology database (MiBa) records laboratory reports from all department of 
clinical microbiology beginning in 2010.10 Information on blood cultures prior to 2010 were 
obtained directly from each individual department of clinical microbiology. Due to difficulties 
extracting data from two departments (2003-2006 for one site and 2003-2009 for the other), 
all patients who had colorectal cancer surgery at these two hospitals were excluded from the 
study for the specified period.  
Data on pathological specimens are coded by clinical pathologists using the Danish version of 
the Systemized Nomenclature of Pathology (SNOMED) and recorded in the Danish 
Pathology Registry.11 This register provided information regarding pathologically diagnosed 
cancer recurrence. 
Study design 
The study was an observational register-based open cohort study, and patients were included 
on day 180 after surgery. Patients who had a blood culture taken within 30 days after surgery 
were included in the exposed group, and all other patients were included as unexposed. 
Recurrence was defined through a validated algorithm using data from NPR and the Danish 






Pathology Registry12 Briefly, the presence of at least one of following four criteria should 
occur: 
1: A metastasis code in NPR occurring at least 180 days after the primary CRC operation and 
with no new primary cancer in the period between primary surgery and registered metastasis 
code. 
2: A cytostatic code registered in NPR with initiation date more than 180 days after primary 
CRC surgery, and more than 60 days after last adjuvant cytostatic code, and without a new 
primary cancer in the period from primary surgery to date of new or first cytostatic therapy 
code. 
3: A SNOMED combination indicating recurrence in NPR within 180 days from primary 
surgery and with no new cancer registered in the period from primary CRC surgery to day of 
SNOMED registered recurrence. 
4: An NPR-registered code for local CRC recurrence at any time after primary diagnosis. 
NPR codes for metastasis and cytostatic treatment did not indicate which primary cancer the 
codes were related to. Therefore, patients with other primary cancers prior to CRC-surgery 
were excluded except for a diagnosis of non-melanoma skin cancer. 
Overall survival was defined as survival from day 180 after surgery to death by any cause. 
Patients were censored at end of follow-up, recurrence, or a new primary cancer of any type. 
Disease-free survival was defined as the time from 180 days after surgery to any of the 
events: recurrence, new primary cancer or death by any cause, and patients were censored at 






end of follow-up. Recurrence-free survival was defined as the period from 180 days after 
surgery to cancer recurrence, and patients were censored at end of follow-up, new primary 
cancer or death by any cause.   
Statistical methods  
Follow-up period with presentation of the non-adjusted overall survival for the two groups 
was illustrated by Kaplan-Meier curves. A Cox proportional regression model was used to 
estimate overall survival, disease-free survival and recurrence-free survival. The model was 
adjusted for age, sex, comorbidity, body mass index (BMI), blood transfusion, smoking 
habits, alcohol consumption, type of surgery (acute or elective), type of cancer (colon or 
rectum), T-stage (pathological), N-stage (positive lymph nodes in the resected specimen or 
not), infectious and non-infectious post-operative complications, and time to chemo- or 
radiotherapy (estimated as therapy initiated within four weeks, between four and eight weeks, 
and eight weeks after CRC surgery). Missing data on BMI, alcohol, smoking, type of surgery, 
T-stage, N-stage, and complications was handled with multiple imputation with 20 imputed 
datasets. Imputation was carried out with all variables included. Competing risk analysis for 
risk of recurrence taking account of mortality was performed using the sub-distribution hazard 
regression model by Fine and Gray 13. Results were presented as hazard ratios (HR) with 95% 
confidence intervals (CI). Statistical analysis was performed using SAS® Proprietary Software 
9.4, SAS institute Inc, Cary, NC. 






The study was approved by the Danish Data Protection agency (file no: 2008-58-0020) and 
the report was written according to recommendations in Strengthening of the Reporting of 
Observational Studies in Epidemiology (STROBE).14 
RESULTS 
The study included 21,349 patients and 3,390 (15.9%) had blood cultures taken. Of these, 561 
(16.5%) were positive, and 2,829 (83.5%) were negative (Figure 1). Median follow-up time 
was 5.6 years (range: 1 day to 13.5 years) (Figure 2).  
In the study period, 8,541 patients died, and 6,583 had recurrent disease. In the non-exposed 
group, this constituted 39.1% who died, and 30.3% who had recurrent disease. In the exposed, 
44.8% died and 33.5% had recurrent disease.   
In the exposed group, there were more male patients, more who experienced a post-operative 
complication, had blood transfusions, had a CCI level of 3 or above, had surgery on acute 
indication, had cancer infiltrated lymph nodes, initiated chemotherapy more than eight weeks 
after surgery, and had surgery in the late period from 2011 to 2013 (Table 1). All these factors 
were included in the Cox regression model.  
The group of patients who had blood cultures taken had an adjusted HR of 1.27 (95% CI 
1.20-1.35 p<0,0001) for higher risk of all-cause mortality. For poorer disease-free survival 
adjusted HR was 1.22 (1.16-1.29 p<0,0001 and for higher risk of recurrence, adjusted HR was 
1.15 (95% CI 1.07-1.23 p<0.0001), compared with the group of patients that did not have 
blood cultures taken (Table 2). 






Sub-distribution HR for competing risks in the analysis of recurrence was 1.11 (p=0.004) 
which is comparable to the Cox regression model. Repeating the analyses without adjusting 
for infectious post-operative complications did not change the HR estimates. 
In a subgroup analysis of patients who had blood cultures taken, there was no association 
between positive versus negative blood cultures and risk of recurrence or disease-free 
survival, but there was a higher risk of all-cause mortality for patients with positive blood 









Patients who had blood cultures taken within 30 days after primary CRC surgery had an 
increased risk of all-cause mortality, poorer disease-free survival and increased risk of cancer 
recurrence, compared with patients who did not have blood cultures taken. Similarly, previous 
studies have found that infectious post-operative complications or merely a systemic 






inflammatory response after surgery for CRC, increased the risk of early and late mortality 
and morbidity.15–17 This study suggests that an excess systemic inflammatory response may 
be associated with recurrence.  
In a subgroup analysis of patients who had blood cultures performed there was a higher risk 
of all-cause mortality in patients with positive cultures, similar to a previous study that found 
a high mortality in patients with bacteraemia after elective surgery.19 There was no 
association to recurrence or disease-free survival. The subgroup included only 561 patients 
with positive cultures, thus limiting the statistical power to draw a firm conclusion.  
The causal link between postoperative systemic inflammation and increased risk of 
recurrence, has been demonstrated in ex vivo and animal studies, and associated to both 
angiogenesis, growth and increased epithelial permeability, all factors promoting the 
metastatic process in the postoperative period.20–25 
There are limitations to the study, which must be considered. There were demographical 
differences between the two groups, and even though many factors known to be related to 
cancer outcome were adjusted for in the model, unmeasured confounding may still be present. 
Patients who had neoadjuvant treatment, or comorbidities such as diabetes and steroid 
dependent patients may be more prone to postoperative infectious complications, and poor 
long-term cancer outcomes. Though CCI was implemented in the model, a more precise 
patient stratification was not possible.  Furthermore, patients in the exposed group generally 
had a later postoperative initiation of chemotherapy, which may further worsen the 
oncological outcome.26  






The study carries a high external validity as the patients represented an unselected national 
cohort of patients who had surgery for CRC with curative intent in Denmark from 2003-2013, 
including national data regarding blood cultures. There was practically no loss to follow-up, 
due to the completeness of the national registers, and the risk of selection bias was therefore 
limited.     
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Figure 1: Flow diagram of study cohort. 
Figure 2: Kaplan-Meier curve of unadjusted all-cause mortality for patients undergoing 
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Table 1: Demographic data in 21,349 patients undergoing colorectal cancer surgery 2003-
2013. 
  No blood cultures 
n = 17959 
Blood cultures 
n = 3390 
Age, n (%) <50 835 (4.7) 153 (4.5) 
 50-60 2382 (13.3) 445 (13.1) 
 60-70 5,169 (28.8) 1,062 (31.3) 
 70-80 5,829 (32.5) 1,162 (34.3) 
 > 80 3,744 (20.8) 568 (16.8) 
Sex, n (%) Male 9,120 (50.8) 2,111 (62.3) 
BMI (kg/m2), n (%) <18.5 455 (2.5) 90 (2.6) 
 18.5-24 6,613 (36.8) 1,137 (33.5) 
 25-30 4,982 (27.7) 1,049 (30.9) 
 30-35 1,601 (8.9) 367 (10.8) 
 >35 486 (2.7) 134 (3.9) 
 Missing information 3,822 (21.3) 613 (18.1) 
This article is protected by copyright. All rights reserved.
Smoking, n (%) Current smoker 2,844 (15.8) 623 (18.4) 
 Former smoker 5,912 (32.9) 1,268 (37.4) 
 Never smoker 5,225 (29.1) 852 (25.1) 
 Missing information 3,978 (22.2) 647 (19.1) 
Alcohol, n (%) 0 3,468 (19.3) 625 (18.4) 
 1-14 8,065 (44.9) 1,532 (45.2) 
 15-21 1,044 (5.8) 251 (7.4) 
 >21 1,139 (6.3) 307 (9.1) 
 Missing information 4,243 (23.6) 675 (19.9) 
Comorbidity n (%) 0 14,124 (78.6) 2,460 (72.6) 
 1 2,497 (13.9) 543 (16.0) 
 2 879 (4.9) 218 (6.4) 
 3 459 (2.6) 169 (5.0) 
Cancer type, n (%) Colon 11,933 (66.4) 2,056 (60.6) 
 Rectum 6,026 (33.5) 1,334 (39.3) 
Type of surgery, n (%) Acute 1,265 (7.0) 437 (12.9) 
 Elective 16,576 (92.3) 2,916 (86.0) 
This article is protected by copyright. All rights reserved.
 Missing information 118 (0.7) 37 (1.1) 
T-stage, n (%) 1 1,506 (8.4) 232 (6.8) 
 2 2,958 (16.5) 507 (15.0) 
 3 10,736 (59.8) 1,997 (58.9) 
 4 2,337 (13.0) 589 (17.4) 
 Missing information 422 (2.3) 65 (1.9) 
Regional lymph node 
metastasis, n (%) 
No 11,202 (62.4) 1,931 (57.0) 
 Yes 6,093 (33.9) 1,394 (41.1) 
 Missing information 664 (3.7) 65 (1.9) 
Non-infectious 
complications, n (%)  
No 17,505 (97.5) 2975 (87.8) 
 Yes 352 (2.0) 397 (11.7) 
 Missing information 102 (0.6) 18 (0.5) 
Blood transfusion,  
n (%) 
No 14,664 (81.6) 2,430 (71.7) 
 Yes 2,894 (16.1) 907 (26.8) 
 Missing information 401 (2.2) 53 (1.6) 
This article is protected by copyright. All rights reserved.
Initiation of chemo- or 
radiotherapy, n (%) 
< 4 weeks  771 (4.3) 103 (3.0) 
 4-8 weeks 3,235 (18.0) 675 (19.9) 
 > 8 weeks 940 (5.2) 353 (10.4) 
 No 13,013 (72.5) 2,259 (66.6) 
Year of surgery, n (%) 2003-2006 6,263 (34.9) 865 (25.5) 
 2007-2010 6,569 (36.6) 1,139(33.6) 
 2011-2013 5,127 (28.6) 1,386 (40.9) 
 
BMI: Body Mass Index  
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Table 2: Cancer recurrence, disease-free survival and all-cause mortality assessed by Cox 
proportional regression model in patients who had blood cultures taken within 30 days after 
primary colorectal cancer surgery, compared to patients that did not. 
 
  HR 95% CI P HRadjusted* 95% CI P 
Higher risk of recurrence  
      
No blood-culture 1   1   
Blood-culture 1.30 1.22-1.39 <0.0001 1.15 1.07-1.23 <0.0001 
Poorer disease-free survival       




Blood-culture 1.36 1.30-1.43 <0.0001 1.22 1.16-1.29 <0.0001 
Higher risk of mortality       
No blood-culture 1   1   
Blood-culture 1.41 1.33-1.49 <0.0001 1.27 1.20-1.35 <0.0001 
 
HR: Hazard Ratio, CI: 95% Confidence Intervals 
* Adjusted for age, gender, comorbidity, smoking habits, alcohol consumption, post-operative blood transfusions, type 
of surgery (acute or elective), BMI, T-stage, lymph node positivity, non-infectious post-operative complications, 
infectious post-operative complications, year of surgery, and initiation of chemo-/radiotherapy.  
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